Daiichi Jitsugyo Co (8059) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Sep, 2025Executive summary
Net sales for Q3 reached 160.776 billion yen, up 43.331 billion yen year-over-year, achieving record highs and 80.4% of the full-year forecast.
Operating income rose by 5.445 billion yen to 9.959 billion yen, nearly meeting the full-year forecast at 99.6% and up 120.6% year-over-year.
Profit attributable to owners of parent increased by 2.967 billion yen to 7.256 billion yen, up 69.2% year-over-year.
Basic earnings per share increased by 93.41 yen to 228.72 yen, reflecting a 3-for-1 stock split.
Financial highlights
Gross profit: 27.593 billion yen (up 6.779 billion yen YoY); selling, general and administrative expenses: 17.634 billion yen.
Ordinary income: 10.223 billion yen (up 5.459 billion yen YoY, more than doubled YoY).
Comprehensive income: 7.088 billion yen, nearly unchanged from the prior year.
EPS: 228.72 yen (up 93.41 yen YoY).
Outlook and guidance
Full-year forecast: net sales 200 billion yen, operating income 10 billion yen, profit attributable to owners of parent 7.3 billion yen, EPS 230.09 yen.
Progress against FY2024 forecast: net sales at 80.4%, operating income at 99.6%, ordinary income at 99.3%, profit attributable to owners of parent at 99.4%.
Annual dividend forecast: 77 yen per share, with a year-end forecast of 36 yen.
Latest events from Daiichi Jitsugyo Co
- Record Q3 profits and strong segment growth support an upwardly revised full-year outlook.8059
Q3 20264 Feb 2026 - Record Q2 sales and profits led to upward revisions in full-year forecasts and dividends.8059
Q2 20267 Nov 2025 - Record-high sales and profit, improved equity ratio, and strong full-year outlook.8059
Q2 20259 Sep 2025 - Record sales and profits, strong overseas growth, and a conservative outlook for next year.8059
Q4 20259 Sep 2025 - Record Q1 sales and profits driven by Healthcare and Automobile, but outlook is slightly cautious.8059
Q1 20269 Sep 2025 - Strong sales and profit growth, with robust outlook and improved equity ratio.8059
Q1 20259 Sep 2025